MedPath

Impact of Protein Content of Ultraprocessed Foods on the Regulation of Energy Balance

Not Applicable
Completed
Conditions
Healthy
Registration Number
NCT05337007
Lead Sponsor
University of Kiel
Brief Summary

Aim of the study is to investigate the effects of high-protein, ultraprocessed foods on the regulation of energy balance in a metabolic chamber. The primary outcome parameter of the study is the energy balance (ad libitum energy intake and energy expenditure).

Detailed Description

Each of the two study weeks starts with a 3-day run-in period with controlled diet at home, following 48 hours in a metabolic chamber. On the day the participants leave the metabolic chamber, they keep a food record over the rest of the day at home.

1. week: meals containing 30 % protein (80 % ultraprocessed high-protein foods), physical activity level (PAL) 1.45, 2 intervention days in the metabolic chamber: ad libitum energy intake

2. week: meals containing 13 % protein (80 % ultraprocessed foods with moderate protein content), physical activity level (PAL) 1.45, 2 intervention days in the metabolic chamber: ad libitum energy intake

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
24
Inclusion Criteria
  • healthy
  • BMI 19-29 kg/m2
  • low-medium habitual physical activity
  • women with regular menstrual cycle (during intervention in follicular phase)
Exclusion Criteria
  • smoking
  • chronic illnesses (e.g. renal dysfunction)
  • regular intake of medication
  • food allergies / intolerances
  • vegans and vegetarians
  • regular high physical activity (exercise >1 hour/d)
  • current weight loss diet / weight loss of >5 kg in the last 3 months
  • pregnant / lactating women
  • persons incapable of giving informed legal consent
  • restraint eaters (according to the German version of the 'Three-Factor-Eating-Questionnaire', Stunkard und Messick (1985))

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Primary Outcome Measures
NameTimeMethod
ad libitum energy intake24 hours

ad libitum energy intake (kcal/day) of the foods consumed (breakfast, lunch, dinner, snacks)

energy expenditure24 hours

measured with indirect calorimetry in a metabolic chamber (kcal/day)

Secondary Outcome Measures
NameTimeMethod
macronutrient oxidation24 hours

measured with indirect calorimetry in a metabolic chamber (respiratory quotient, RQ)

gastric emptying5 hours after breakfast on first day of each intervention; intervals 15 min

measured with 13C-octanoic acid breath test

appetite regulating hormone - GLP-15 hours after breakfast on second day of each intervention; intervals 30 min

Glucose Like Peptide-1 concentration in plasma (15 hours AUC; pg/mL)

appetite regulating hormone - PYY5 hours after breakfast on second day of each intervention; intervals 30 min

Peptide YY concentration in plasma (15 hours AUC; pg/mL)

appetite control - subjective feelings of hunger5 hours after breakfast on first day of each intervention; intervals 30 min

measured with visual analogue scales (5 hours AUC; mm x 5 hours). The scale consists of a 10 cm vertical line anchored with "not hungry at all" at the left side and with "extremely hungry" at the right side.

glycemia - glucose AUC24 hours

glucose AUC from continuous glucose monitoring data (mg/dL x 24 hours)

eating rate3 x 30 per 24 hours (during main meals)

time to finish the meals (breakfast, lunch, dinner), (kcal/min; g/min)

oral processing behaviour (chewing)3 x 30 per 24 hours (during main meals)

chews per bite, bite size, oral exposure per bite

appetite regulating hormone - ghrelin5 hours after breakfast on second day of each intervention; intervals 30 min

Ghrelin concentration in plasma (15 hours AUC; pg/mL)

Trial Locations

Locations (1)

Institute of Human Nutrition

🇩🇪

Kiel, Germany

Institute of Human Nutrition
🇩🇪Kiel, Germany
© Copyright 2025. All Rights Reserved by MedPath